NewCardio, Inc. (NWCI)

Market Cap	41.00 -100.0%
Revenue (ttm)	238.58K +40.9%
Net Income	-8.84M
EPS	-0.28
Shares Out	40.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	260,100
Open	0.0001
Previous Close	n/a
Day's Range	0.000001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	-122.71
Analysts	Hold
Price Target	1.25 (+124,999,900.0%)
Earnings Date	n/a

About NewCardio

NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company’s technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 10
• Stock Exchange: OTCMKTS
• Ticker Symbol: NWCI

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 19, 2026

Data Sources Report a data error